quinoxalines has been researched along with ADDH in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fraser, K | 1 |
Cocores, JA; Gold, MS | 1 |
Furberg, CD; Glenmullen, J; Moore, TJ | 1 |
Moorman, KL; Whitley, HP | 1 |
de Villiers, AS; Jaffer, A; Russell, VA; Sagvolden, T; Searson, A; Taljaard, JJ | 1 |
Allie, S; Russell, V; Wiggins, T | 1 |
6 other study(ies) available for quinoxalines and ADDH
Article | Year |
---|---|
72nd annual meeting of the American Academy of Dermatology.
Topics: Antifungal Agents; Attention Deficit Disorder with Hyperactivity; Boron Compounds; Botulinum Toxins, Type A; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Depression; Dermatitis, Atopic; Food Hypersensitivity; Humans; Immunologic Factors; Ivermectin; Phosphodiesterase Inhibitors; Phototherapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinoxalines; Skin Diseases; Societies, Medical; Thalidomide; Triazoles; United States | 2014 |
Varenicline and adult ADHD.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Benzazepines; Female; Humans; Nicotinic Antagonists; Psychiatric Status Rating Scales; Quinoxalines; Varenicline | 2008 |
Prescription drugs associated with reports of violence towards others.
Topics: Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzazepines; Humans; Hypnotics and Sedatives; Outcome Assessment, Health Care; Pharmaceutical Preparations; Prescription Drugs; Prospective Studies; Quinoxalines; United States; United States Food and Drug Administration; Varenicline; Violence | 2010 |
Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine.
Topics: Adolescent; Amphetamines; Attention Deficit Disorder with Hyperactivity; Benzazepines; Central Nervous System Stimulants; Dextroamphetamine; Drug Combinations; Drug Interactions; Humans; Male; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline | 2007 |
Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Antihypertensive Agents; Attention Deficit Disorder with Hyperactivity; Biogenic Monoamines; Brimonidine Tartrate; Disease Models, Animal; Dopamine; Hypertension; In Vitro Techniques; Male; Neurons; Norepinephrine; Nucleus Accumbens; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha-2; Tritium | 1995 |
Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Attention Deficit Disorder with Hyperactivity; Brimonidine Tartrate; Disease Models, Animal; Dopamine; Down-Regulation; Hypertension; Idazoxan; In Vitro Techniques; Male; Models, Neurological; Norepinephrine; Prefrontal Cortex; Quinoxalines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Long-Evans; Receptors, Adrenergic, alpha-2 | 2000 |